neutralization detection kit cpass (GenScript corporation)
90
Structured Review
GenScript corporation
neutralization detection kit cpass
Neutralization Detection Kit Cpass, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpass+kit/cpass+neutralization+antibody+detection+kit/pm40328892-44-13-17
Average 90 stars, based on 1 article reviews
Neutralization Detection Kit Cpass, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cpass+kit/cpass+neutralization+antibody+detection+kit/pm40328892-44-13-17
Average 90 stars, based on 1 article reviews
neutralization detection kit cpass - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Virus:Article Title: Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 Article Snippet: Most (96.8%, n = 4634) of the positive specimens received until April 2021 were frozen at −30 °C and additionally analysed in a plaque reduction neutralisation assay (PRNT) ( n = 647) and/or a surrogate virus neutralisation test (sVNT) ( n = 4246) targeting the Angiotensin Converting Enzyme (ACE) 2 receptor binding domain of the SARS-CoV-2 spike protein (cPassTM Neutralization Antibody Detection Kit, Genscript Biotech, Piscataway Township, NJ, USA). .. A subset of 379 N-positive specimens collected in 2022 was analysed with discriminatory sVNT targeting the wild-type virus or the Omicron variant ( Article Title: Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study. Article Snippet: .. Serology was performed using commercially available test kits from Roche, Wondfo and GenScript Article Title: Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study Article Snippet: .. Serology was performed using commercially available test kits from Roche, Wondfo and GenScript Article Title: Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial. Article Snippet: .. Surrogate virus neutralization test Concentrated BALF neutralizing antibodies were assessed utilizing a surrogate SARS-CoV-2 virus neutralization test (sVNT). sVNT assays were performed utilizing the Article Title: Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial Article Snippet: .. Concentrated BALF neutralizing antibodies were assessed utilizing a surrogate SARS-CoV-2 virus neutralization test (sVNT). sVNT assays were performed utilizing the Variant Assay:Article Title: Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 Article Snippet: Most (96.8%, n = 4634) of the positive specimens received until April 2021 were frozen at −30 °C and additionally analysed in a plaque reduction neutralisation assay (PRNT) ( n = 647) and/or a surrogate virus neutralisation test (sVNT) ( n = 4246) targeting the Angiotensin Converting Enzyme (ACE) 2 receptor binding domain of the SARS-CoV-2 spike protein (cPassTM Neutralization Antibody Detection Kit, Genscript Biotech, Piscataway Township, NJ, USA). .. A subset of 379 N-positive specimens collected in 2022 was analysed with discriminatory sVNT targeting the wild-type virus or the Omicron variant ( Neutralization:Article Title: Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 Article Snippet: Most (96.8%, n = 4634) of the positive specimens received until April 2021 were frozen at −30 °C and additionally analysed in a plaque reduction neutralisation assay (PRNT) ( n = 647) and/or a surrogate virus neutralisation test (sVNT) ( n = 4246) targeting the Angiotensin Converting Enzyme (ACE) 2 receptor binding domain of the SARS-CoV-2 spike protein (cPassTM Neutralization Antibody Detection Kit, Genscript Biotech, Piscataway Township, NJ, USA). .. A subset of 379 N-positive specimens collected in 2022 was analysed with discriminatory sVNT targeting the wild-type virus or the Omicron variant ( Article Title: Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study. Article Snippet: .. Serology was performed using commercially available test kits from Roche, Wondfo and GenScript Article Title: Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients Article Snippet: .. A previous study reported a strong correlation between nAb levels measured using a Article Title: Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study Article Snippet: .. Serology was performed using commercially available test kits from Roche, Wondfo and GenScript Article Title: Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial. Article Snippet: .. Surrogate virus neutralization test Concentrated BALF neutralizing antibodies were assessed utilizing a surrogate SARS-CoV-2 virus neutralization test (sVNT). sVNT assays were performed utilizing the Article Title: Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients. Article Snippet: .. A previous study reported a strong correlation between nAb levels measured using a Article Title: Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial Article Snippet: .. Concentrated BALF neutralizing antibodies were assessed utilizing a surrogate SARS-CoV-2 virus neutralization test (sVNT). sVNT assays were performed utilizing the Generated:Article Title: Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus Article Snippet: .. Using these values, we were able to calculate that hAd5 S-Fusion+N-ETSD vaccination generated a geometric mean value of 5.8 S-specific IgG and 42 μg N-specific IgG per milliliter of serum. cPassTM Neutralizing Blocking Assay:Article Title: Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus Article Snippet: .. Using these values, we were able to calculate that hAd5 S-Fusion+N-ETSD vaccination generated a geometric mean value of 5.8 S-specific IgG and 42 μg N-specific IgG per milliliter of serum. cPassTM Neutralizing Cell Surface Receptor Assay:Article Title: Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus Article Snippet: .. Using these values, we were able to calculate that hAd5 S-Fusion+N-ETSD vaccination generated a geometric mean value of 5.8 S-specific IgG and 42 μg N-specific IgG per milliliter of serum. cPassTM Neutralizing |